Psychotic Disorders: all 1,655 studies
Page 12 of 17. Open to participants first (298), then studies with results posted, then the rest; newest registration first within each.
- Stress and Mental Ill-health in the Workplace: Evaluation of an Intervention for the Prevention of Sick LeaveCompletedNCT02563743Not applicable
- Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-upCompletedNCT02534363Phase 4
- Minocycline Augmentation of Clozapine for Treatment Resistant SchizophreniaStatus unknownNCT02533232Phase 1
- Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-upStatus unknownNCT02532491Phase 4
- Computer-Aided Learning for Managing StressCompletedNCT02531243Not applicable
- Evaluating the Efficacy of a Late-Life Schizophrenia Integrated Care Pathway to Treat Acute Psychotic SymptomsStatus unknownNCT02529163Not applicable
- Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-upCompletedNCT02526030Phase 4
- Role Functioning Changes NOSTerminatedNCT02505022
- Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or SchizoaffectiveCompletedNCT02504476Phase 1
- Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET StudyWithdrawnNCT02492074Phase 1
- Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different CannabinoidsCompletedNCT02487381Phase 1
- Effect of N-acetylcysteine on Brain GlutamateCompletedNCT02483130
- A Pilot Trial of Curcumin Effects on Cognition in SchizophreniaTerminatedNCT02476708Not applicable
- Self-Management and Recovery Technology Psychosocial Intervention TrialCompletedNCT02474524Not applicable
- Adaptation of Cognitive Enhancement Therapy for Persons at Clinical High Risk for PsychosisCompletedNCT02459210Not applicable
- Acceptance & Commitment Therapy for Psychotic InpatientsWithdrawnNCT02458105Not applicable
- The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled TrialCompletedNCT02453217Not applicable
- Study of Immunotherapy in Autoantibody Positive PsychosisCompletedNCT02449746Not applicable
- TechCare: Mobile-AssessmenT and ThErapy for PsyCHosis: An Intervention for Clients Within the EArly InteRvention SErviceStatus unknownNCT02439619Not applicable
- A Pharmacokinetic Study of Paliperidone ERStatus unknownNCT02433717Phase 4
- The Music Study in Refractory PsychosisStatus unknownNCT02431949
- A Study of the Effectiveness of Cognitive Adaptation Training in Early Intervention for PsychosisCompletedNCT02430935Not applicable
- Feasibility Trial of CBT for Depersonalisation in PsychosisCompletedNCT02427542Phase 1
- Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental IllnessCompletedNCT02421965Not applicable
- OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) GrantCompletedNCT02415764Phase 1
- Longitudinal Family/Molecular Genetic Study to Validate Research Domain CriteriaCompletedNCT02415647
- Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable SchizophreniaCompletedNCT02411526Phase 1
- Cannabinoids, Learning, and MemoryActive, not recruitingNCT02407808Phase 1
- Targeted Cognitive Training in Clinical High Risk (CHR) for PsychosisCompletedNCT02404194Not applicable
- Zurcher Adolescent Screening for Mental DisorderCompletedNCT02401984
- Social Cognition and Interaction Training for Adults With Psychotic Disorders: An Open Pilot Study in FinlandCompletedNCT02399020Not applicable
- A Multi-modal Approach to Addressing Cardiovascular Risk and Building Resilience in Youths With PsychosisCompletedNCT02398292Not applicable
- L-arginine add-on Therapy in Patients With SchizophreniaCompletedNCT02398279Not applicable
- Problem-solving-based Bibliotherapy Program for Family CaregiversCompletedNCT02391649Not applicable
- Efficiency of Art-therapy in Psychotic DisordersTerminatedNCT02383095Not applicable
- Improving Care and Reducing Cost StudyCompletedNCT02364544Not applicable
- Cognitive Remediation Therapy Within a Secure Forensic SettingCompletedNCT02360813Not applicable
- Participatory Video as a Recovery-Oriented Intervention in Early PsychosisCompletedNCT02360566Not applicable
- Selective Estrogen Receptor Modulators for Women of Child-bearing Age With SchizophreniaCompletedNCT02354001Phase 4
- A Shared Decision-making Training for Inpatients With SchizophreniaCompletedNCT02349880Not applicable
- Mindfulness Group-based Intervention for Early Psychosis: A Pilot StudyCompletedNCT02342210Not applicable
- Effectiveness of Meta-Cognitive Training (EMC) in People With Psychosis of Brief Evolution.CompletedNCT02340559Not applicable
- Perceptual Deficits in SchizophreniaStatus unknownNCT02337439Not applicable
- Researching the Effectiveness of Acceptance-Based Coping During HospitalizationCompletedNCT02336581Not applicable
- Evaluation of A Statewide Program to Prevent Early Mortality and to Promote Fitness in Persons With SMICompletedNCT02334280Not applicable
- Evaluation of the In SHAPE Fitness Intervention for Adults With Serious Mental IllnessCompletedNCT02334228Not applicable
- Exercise and Cognitive TrainingCompletedNCT02326389Not applicable
- The BC Psychosis Program Biobank and Database for Genetic Polymorphisms and Their Associations With Psychosis DisorderStatus unknownNCT02322918
- Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up StudyCompletedNCT02321943
- COGNITIVE BEHAVIORAL THERAPY PROGRAM TO FIRST-EPISODE PSYCHOSIS PATIENTS AND CANNABIS ABUSECompletedNCT02319746Not applicable
- Task Sharing for the Care of Severe Mental Disorders in a Low-income CountryCompletedNCT02308956Phase 3
- Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic PatientsCompletedNCT02307396Phase 4
- Well Being And Resilience: Mechanisms of Transmission of Health and RiskCompletedNCT02306551
- Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective PsychosisCompletedNCT02305823Phase 4
- Manualized Group Cognitive-behavioral Therapy for Social Anxiety in First Episode PsychosisCompletedNCT02294409Not applicable
- Study of the Effect of Dosing on Clozapine LevelsWithdrawnNCT02286206Phase 4
- Peer Support for Severe Mental DisordersCompletedNCT02276469Not applicable
- Enhancing Cognitive Training Through Exercise After a First Schizophrenia EpisodeCompletedNCT02267070Not applicable
- Mindfulness RCT for Early PsychosisStatus unknownNCT02244970Not applicable
- Cognitive Behavioral Social Skills Training for Youth at Risk of PsychosisCompletedNCT02234258Not applicable
- Prediction of Relapse in Schizophrenia/Schizoaffective Disorder With Smartphones and On-body SensorsCompletedNCT02224430
- Efficacy of Repetitive Transcranial Magnetic Stimulation in the Prevention of Relapse of SchizoaffectiveStatus unknownNCT02221635
- 3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis IndividualsCompletedNCT02220504Not applicable
- Psychosis and Affective Research Domains and Intermediate PhenotypesCompletedNCT02218853
- Treating Co-Occurring Substance Use and Mental Disorders Among Jail InmatesTerminatedNCT02214667Not applicable
- Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric MedicationsWithdrawnNCT02213887Phase 4
- Electronic Cigarettes in Smokers With Mental IllnessCompletedNCT02212041Not applicable
- Culturally Adapted Cognitive Behavior Therapy for Psychosis in PakistanCompletedNCT02202694Not applicable
- The Potential Biomark of Serious Psychosis:a Prospective,Case-controled StudyStatus unknownNCT02202460
- Longitudinal Long-term Study (10 Years) of the Sample of First Episode of Non-affective Psychosis: PAFIPStatus unknownNCT02200588
- Self Directed Positive Parenting Program (Triple P) for Psychosis: A Clinical Case SeriesCompletedNCT02199704Not applicable
- Targeted Vitamin D Treatment of Schizophrenia-Associated HyperprolinemiaWithdrawnNCT02197286Phase 2
- Computerized Cognitive-Behavioral Therapy for Auditory HallucinationsCompletedNCT02192593Not applicable
- Self-Management Training and Automated Telehealth to Improve SMI Health OutcomesCompletedNCT02188732Not applicable
- An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT02186769Phase 1
- Group Training for Social Skills in PsychosisCompletedNCT02181777Not applicable
- Short-term Working Memory and Executive TrainingCompletedNCT02168166Not applicable
- Culturally Adapted Family Intervention For PsychosisCompletedNCT02167347Not applicable
- RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia)CompletedNCT02160249Not applicable
- Electroconvulsive Therapy in Clozapine-resistant SchizophreniaStatus unknownNCT02159001Not applicable
- Examining Dose-Related Effects of Oxytocin on Social Cognition Across PopulationsTerminatedNCT02149823Phase 1
- Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With SchizophreniaCompletedNCT02137993Phase 4
- Antipsychotic to Treat Psychosis SyndromeStatus unknownNCT02137616Not applicable
- Integrated Metacognitive Therapy in First Episode PsychosisCompletedNCT02131116Not applicable
- An Acceptance-Based Behavioral Intervention vs. Nutritional Counselling for Weight Loss in Psychotic IllnessCompletedNCT02130596Not applicable
- Remote Cognitive RemediationCompletedNCT02121106Not applicable
- Probing the Cannabinoid System in Individuals With a Family History of PsychosisActive, not recruitingNCT02102113Early Phase 1
- Intervention Module AGESCompletedNCT02101372Not applicable
- Effects of Neurocognitive and Social Cognitive Remediation in Patients at Ultra-High Risk of PsychosisCompletedNCT02098408Not applicable
- Family-Focused Therapy for Youth With Early-Onset Bipolar or Psychotic DisordersCompletedNCT02097563Phase 2
- Association of Amisulpride Response in Schizophrenia With Brain ImageStatus unknownNCT02095938Phase 4
- Routine Outcome Monitoring in Mental Health OutpatientStatus unknownNCT02095457Not applicable
- Bioavailability of LY03004 and Risperdal® Consta®CompletedNCT02091388Phase 1
- Health Promotion and Fitness for Younger and Older Adults With SMICompletedNCT02090335Not applicable
- Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric ParticipantsCompletedNCT02087579Phase 1
- Effects of a Walking Program in People With Mental DisordersCompletedNCT02079012Not applicable
- Implementation of Illness Management and Recovery in Mental Health ServicesCompletedNCT02077829Not applicable
- Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ERCompletedNCT02075528Phase 4
- RCT of Methotrexate Added to Treatment As Usual in SchizophreniaCompletedNCT02074319Phase 1
- Study of Web- Based Cognitive Behavioral Therapy for Depressed Korean AdolescentsStatus unknownNCT02072304Not applicable